Fu, Wang
Yu, Xiaoming
Lai, Minghui
Li, Yuanli
Yang, Yingting
Qin, Yong
Yu, Min
Wang, Feng
Wang, Cong http://orcid.org/0000-0003-2289-2794
Funding for this research was provided by:
National Natural Science Foundation of China (82202787)
Frontier Innovative Talents of Traditional Chinese Medicine Program of Shanghai University of Traditional Chinese Medicine (009)
Shanghai Municipal Science and Technology Commission (23Y11906400)
Research Project of the Shanghai Municipal Health Commission (20234Y0241)
Outstanding Leaders Training Program of Pudong Health Bureau of Shanghai (PWR12020-03)
Pudong New Area Science and Technology Development Fund for Livelihood Research Special Project (PKJ2023-Y60)
Discipline Construction of Pudong Health Bureau of Shanghai—Discipline group of cerebrovascular system diseases (PWZxq2022-01)
Article History
Received: 17 January 2024
Accepted: 16 April 2024
First Online: 26 April 2024
Declarations
:
: This protocol has been approved by the Ethics Committee of the Seventh People’s Hospital of Shanghai (Approval Number: 2023-7th-HIRB-027) and will be conducted in accordance with the ethical standards outlined in the Helsinki Declaration. The study protocol has also been registered with the Chinese Clinical Trial Registry (ChiCTR) under the registration number ChiCTR2300076579. All patients will provide written consent for participation and publication of trial data.
: The participant information materials and informed consent form are available from the corresponding author on request.
: The authors declare that they have no competing interests.